DANSK DS/ISO 10993-17 PDF

DANSK DS/ISO 10993-17 PDF

Name:
DANSK DS/ISO 10993-17 PDF

Published Date:
11/29/2023

Status:
[ Active ]

Description:

Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents

Publisher:
Dansk Standard

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$36.6
Need Help?

This document specifies the process and requirements for the toxicological risk assessment of medical device constituents. The methods and criteria used to assess whether exposure to a constituent is without appreciable harm are also specified. The toxicological risk assessment can be part of the biological evaluation of the final product, as described in ISO 10993-1. The process described in this document applies to chemical characterization information obtained in line with ISO 10993-18. When a toxicological risk assessment of either the compositional information or analytical chemistry data (e.g. extractable data or leachable data) are required to determine whether the toxicological risks related to the constituents are negligible or tolerable. The process described in this document is not intended to apply to circumstances where the toxicological risk has been estimated by other means, such as: –    constituents, excluding cohort of concern or excluded chemicals, that are present in or extracted from a medical device at an amount representative of patient exposure below a relevant, toxicologically-based reporting threshold (see applicable requirements in ISO 10993-18:2020, Annex E and ISO/TS 21726); –    a new or changed medical device for which chemical or biological equivalence has been established with an existing biocompatible or clinically established medical device (see applicable requirements in ISO 10993-18:2020, Annex C). The process described in this document is also not applicable to: –    medical device constituents that do not contact the body (e.g. in vitro diagnostics); –    biological risks associated with physical interactions of the medical device with the body (i.e. application of mechanical forces, energy or surface morphology, etc.), provided that the chemical exposure is not changed; –    active pharmaceutical ingredients of device-drug combination products or biologic components of device-biologic combination products as additional regulatory considerations can apply; –    exposure to a particular constituent that arises from sources other than the device, such as food, water or air.


Edition : 23#
File Size : 1 file , 2.4 MB
Number of Pages : 74
Product Code(s) : DS-061, DS-061
Published : 11/29/2023

History

DANSK DSF/ISO/DIS 10993-17
Published Date:
Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents
$16.2
DANSK DS/ISO 10993-17
Published Date: 11/29/2023
Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents
$36.6

Related products

DANSK DS/EN 13892-7
Published Date: 09/24/2003
Methods of test for screed materials - Part 7: Determination of wear resistance to rolling wheel of screed material with floor coverings
$13.2
DANSK DS/EN ISO 10283
Published Date: 09/14/2007
Binders for paints and varnishes - Determination of monomeric diisocyanates in isocyanate resins
$15.3
DANSK DS/EN ISO 4651
Published Date: 08/09/1995
Cellular rubbers and plastics - Determination of dynamic cushioning performance
$28.2
DANSK DS/EN 61000-6-3
Published Date: 02/19/2007
Electromagnetic compatibility (EMC) – Part 6-3: Generic standards – Emission standard for residential, commercial and light-industrial environments
$18

Best-Selling Products